로딩 중…
지수 로딩 중…
Immunome, Inc.
IMNM· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$18.74+1.13%
2026-06-18
Price Chart
Immunome, Inc.+112.23%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $2.12B |
| Revenue | $4M |
| Net Income | $-225M |
| Total Assets | $620M |
| Net Assets | $589M |
| Value | |
| P/B | 3.61x |
| P/S | 528.60x |
| FCF Yield | -9.68% |
| Profitability | |
| ROE | -38.15% |
| ROA | -36.24% |
| Op. Margin | -5947.90% |
| Revenue Growth | -100.00% |
| Financial Health | |
| Debt Ratio | 5.28% |
| Total Debt | $4M |
| FCF | $-206M |
| Cash | $583M |
| Current Ratio | 21.68x |
| Performance | |
| 1Y Return | 112.23% |
| 1M Return | -4.68% |
| From 52W High | -32.22% |
| 1Y MDD | -33.59% |
| Trading | |
| Volume | 2,541,657 shares |
| Trading Value | $47M |
| Per Share | |
| EPS | $-2.43 |
| BPS | $7.26 |